acabel dragees
t. p. whelehan son & co. limited - bevonium metilsulfate -
resonium a sodium polystyrene sulfonate powder bottle
sanofi-aventis australia pty ltd - sodium polystyrene sulfonate, quantity: 999.3 mg/g - powder - excipient ingredients: saccharin; vanillin - treatment of hyperkalaemia.
resonium a
polystyrene sulfonate - sodium -
calcium resonium calcium polystyrene sulfonate powder can
sanofi-aventis australia pty ltd - calcium polystyrene sulfonate, quantity: 999.3 mg/g - powder - excipient ingredients: vanillin; saccharin - calcium resonium is an ion-exchange resin. it is recommended for the treatment of hyperkalaemia associated with anuria and severe oliguria.,it is also used to treat hyperkalaemia in patients requiring dialysis and in patients on regular haemodialysis or on prolonged peritoneal dialysis.
resonium-a
pharmacy retailing (nz) ltd t/a healthcare logistics - sodium polystyrene sulfonate 99.934% (binding capacity 3.1meq/g); ; - powder for oral solution - 3.1 meq/g - active: sodium polystyrene sulfonate 99.934% (binding capacity 3.1meq/g) excipient: saccharin sodium vanillin - treatament of hyperkalaemia.
calcium resonium
pharmacy retailing (nz) ltd t/a healthcare logistics - calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g); ; - powder for oral solution - 1.7 meq/g - active: calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g) excipient: saccharin vanillin
resonium a powder
sanofi - sodium polystyrene sulfonate - powder for oral or rectal suspension - 999.34mg/1gram
calcium resonium
catalent australia pty ltd - polystyrene sulfonate - calcium -
resonium calcium powder for solution
sanofi-aventis canada inc - calcium polystyrene sulfonate - powder for solution - 999mg - calcium polystyrene sulfonate 999mg - potassium-removing agents
resonium a 99.934% w/w powder for oral administration